<DOC>
	<DOC>NCT01021527</DOC>
	<brief_summary>A four-period study to evaluate if the grade glucose infusion procedure will be able to detect an increase in beta-cell glucose sensitivity from exenatide compared to no treatment in healthy subjects.</brief_summary>
	<brief_title>A Study to Assess the Effects of Exenatide on Insulin Secretion Rates Using a Graded Infusion of Intravenous Glucose (0000-099)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Exenatide</mesh_term>
	<criteria>Subject is in good health Subject is a nonsmoker Subject has irritable bowel disease Subject has a history of cancer Subject has a history of hypertension requiring treatment Subject is unable to refrain from the use of any prescription or nonprescription medication Subject consumes excessive amounts of alcohol or caffeine Subject has had major surgery, donated blood or participated in another investigational study in the past 4 weeks</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>